SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

143.1

455633.71

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.84

Back

religare enterprises ltd

NCL Research and Financial Services standalone net profit declines 33.53% in the June 2026 quarter

Aug 11,2026

Net profit of NCL Research and Financial Services declined 33.53% to Rs 1.13 crore in the quarter ended June 2026 as against Rs 1.70 crore during the previous quarter ended June 2025. Sales declined 8.24% to Rs 1.67 crore in the quarter ended June 2026 as against Rs 1.82 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.67	1.82	-8
OPM %	56.89	82.42	-
PBDT	1.50	2.28	-34
PBT	1.49	2.27	-34
NP	1.13	1.70	-34

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)